Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ROVATI, L. C")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 51

  • Page / 3
Export

Selection :

  • and

Clinical research in osteoarthritis : design and results of short-term and long-term trials with disease-modifying drugsROVATI, L. C.International journal of tissue reactions. 1992, Vol 14, Num 5, pp 243-251, issn 0250-0868Article

Perspectives of CCK antagonists in pancreatic research and clinical use. IROVATI, L. C.International journal of pancreatology. 1991, Vol 8, Num 3, pp 215-226, issn 0169-4197, 12 p.Article

Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis : A double-blind, randomized, parallel-group, placebo-controlled prospective clinical studyMIGLIO, F; ROVATI, L. C; SANTORO, A et al.Arzneimittel-Forschung. 2000, Vol 50, Num 8, pp 722-727, issn 0004-4172Article

Chronic intrathecal cannulation affects hypothalamic beta-endorphin and met-enkephalin concentrationsROVATI, L. C; SACERDOTE, P; BIANCHI, M et al.Journal of pharmacological methods. 1988, Vol 19, Num 1, pp 85-88, issn 0160-5402Article

Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis : a pilot studyRINGE, J. D; DORST, A; FABER, H et al.Rheumatology international (Berlin. Print). 2005, Vol 25, Num 4, pp 296-300, issn 0172-8172, 5 p.Article

Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjectsWEBBER, C; ROTH, A; CHASSEAUD, L. F et al.Xenobiotica (London. Print). 2003, Vol 33, Num 6, pp 625-641, issn 0049-8254, 17 p.Article

Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patientsPERSIANI, S; D'AMATO, M; MAKOVEC, F et al.Biopharmaceutics & drug disposition. 2001, Vol 22, Num 2, pp 73-81, issn 0142-2782Article

Treatment of postmenopausal vertebral osteopenia with monofluorophosphate : a long-term calcium-controlled studyGAMBACCIANI, M; SPINETTI, A; TAPONECO, F et al.Osteoporosis international. 1995, Vol 5, Num 6, pp 467-471, issn 0937-941XArticle

Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humansVERHULST, M. L; GIELKENS, H. A. J; HOPMAN, W. P. M et al.Regulatory peptides. 1994, Vol 53, Num 3, pp 185-193, issn 0167-0115Article

Effect of duodenal juice on bombesin-stimulated cholecystokinin release during loxiglumide administration in manJEBBINK, M. C. W; JANSEN, J. B. M. J; VAN DER KLEIJ, F. G. H et al.European journal of clinical investigation. 1993, Vol 23, Num 9, pp 529-533, issn 0014-2972Article

Effect of a cholecystokinin antagonist, loxiglumide, on pancreatic secretion in patients with chronic pancreatitisADLER, G; REINSHAGEN, M; BEGLINGER, C et al.Biomedical research. 1990, Vol 11, Num 3, pp 151-156, 6 p.Article

Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonistSETNIKAR, I; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 6, pp 703-707, issn 0004-4172Article

Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonistsMAKOVEC, F; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 11, pp 1265-1268, issn 0004-4172Article

Bioavailability of estradiol from two transdermal patchesSETNIKAR, I; ROVATI, L. C; VENS-CAPPELL, B et al.Arzneimittel-Forschung. 1996, Vol 46, Num 3, pp 307-310, issn 0004-4172Conference Paper

Effect of a low dose of intraduodenal fat on satiety in humans : studies using the type A cholecystokinin receptor antagonist loxiglumideLIEVERSE, R. J; JANSEN, J. B. M; MASCLEE, A. A. M et al.Gut. 1994, Vol 35, Num 4, pp 501-505, issn 0017-5749Article

Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee : a randomised, placebo-controlled, double-blind studyRICHELT, A; FÖRSTER, K. K; FISCHER, M et al.Arzneimittel-Forschung. 1994, Vol 44, Num 1, pp 75-80, issn 0004-4172Article

Characterization of antigastrin activity in vivo of CR 2194, a new R-4-benzamido-5-oxo-pentanoic acid derivativeREVEL, L; FERRARI, F; MAKOVEC, F et al.European journal of pharmacology. 1992, Vol 216, Num 2, pp 217-224, issn 0014-2999Article

CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the optical treatment of asthmaREVEL, L; COLOMBO, S; FERRARI, F et al.European journal of pharmacology. 1992, Vol 229, Num 1, pp 45-53, issn 0014-2999Article

Benzodiazepines and their antagonists interfere with opioid-dependent stress-induced analgesiaROVATI, L. C; SACERDOTE, P; FUMAGALLI, P et al.Pharmacology, biochemistry and behavior. 1990, Vol 6, Num 1, pp 123-126, issn 0091-3057, 4 p.Article

Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreasDOUGLAS, B. R; WOUTERSEN, R. A; JANSEN, J. B. M. J et al.Cancer research (Baltimore). 1989, Vol 49, Num 9, pp 2438-2441, issn 0008-5472Article

Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreasDOUGLAS, B. R; WOUTERSEN, R. A; JANSEN, J. B. M. J et al.Gastroenterology (New York, NY. 1943). 1989, Vol 96, Num 2, pp 462-469, issn 0016-5085, part 1Article

Study into the role of cholecystokinin in bombesin-stimulated pancreatic growth in rats and hamstersDOUGLAS, B. R; WOUTERSEN, R. A; JANSEN, J. B. M. J et al.European journal of pharmacology. 1989, Vol 161, Num 2-3, pp 209-214, issn 0014-2999Article

Dissociation of tolerance and dependence to morphine: a possible role for cholecystokininPANERAI, A. E; ROVATI, L. C; COCCO, E et al.Brain research. 1987, Vol 410, Num 1, pp 52-60, issn 0006-8993Article

Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activityMAKOVEC, F; BANI, M; CHISTE, R et al.Arzneimittel-Forschung. 1986, Vol 36, Num 1, pp 98-102, issn 0004-4172Article

The β-endorphin-induced secretion of growth hormone but not of prolactin is inhibited by an endogenous opioid antagonistCOLLADO-ESCOBAR, D; ROVATI, L. C; GANZETTI, I et al.European journal of pharmacology. 1986, Vol 129, Num 3, pp 385-387, issn 0014-2999Article

  • Page / 3